Adenocarcinoma of the Gastroesophageal Junction
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Gastroesophageal Junction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction [Phase 2, Phase 3]
This clinical trial update covers a Phase 2/3 study of a combined modality therapy for adenocarcinoma of the gastroesophageal junction, focu…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy [Phase 3]
A Phase 3 trial evaluating gefitinib in esophageal cancer that progressed after chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating panitumumab with paclitaxel, carboplatin and 5-FU in potentially resectable gastroesophageal adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction [Phase 3]
Phase 3 clinical trial update reporting on quality-of-life outcomes for patients undergoing total gastrectomy or proximal gastrectomy for ad…
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 1]
Phase 1 trial of Vandetanib combined with Oxaliplatin and Docetaxel in advanced cancer of the esophagus or gastroesophageal junction has bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Phase 2]
Phase 2 trial evaluating doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach, gastroesophagea…